TCL Archive Guest Editorial: FDA Must Address Economic Incentives to Resolve Drug Shortages Permanently February 24, 2012
TCL Archive Congress Passes Biomedical Research Authorization, Regular Appropriations Bill; NCI Gets $1.183 Billion October 19, 1984
TCL Archive Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge? October 7, 2005
TCL Archive $14.7 Million Earmark Of NCI funds Trigger Protest By Advocates, Scientists October 24, 1996
